Literature DB >> 21216831

Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide.

Uzoma N Ibebuogu1, Inna P Gladysheva, Aiilyan K Houng, Guy L Reed.   

Abstract

BACKGROUND: By promoting salt and water excretion, the corin and the atrial natriuretic peptide (ANP) system should help to maintain fluid balance in heart failure. Yet, the development of fluid retention despite high levels of ANP-related peptides suggests that this compensatory system is limited. METHODS AND
RESULTS: Levels of circulating corin (the pro-ANP-converting enzyme) and pro-ANP were measured in hospitalized patients with heart failure, using novel immunoassays. Patients (n=14) had severe heart failure (New York Heart Association class III-IV) with a median ejection fraction of 18% and median brain natriuretic peptide levels of 1940 pg/mL. In heart failure, median plasma corin levels were 7.6-fold lower than measured in plasma from 16 normal control subjects (180 versus 1368 pg/mL, P<0.01). In contrast, in patients with heart failure, levels of plasma N-terminal ANP peptides (N-ANP and pro-ANP) levels were markedly elevated (42.0 versus 7.5 ng/mL, P<0.01). Levels of uncleaved pro-ANP, measured by novel immunoassays, were significantly higher in patients with heart failure (P<0.01), suggesting that corin cleavage of pro-ANP was impaired. Median plasma levels of cyclic guanosine monophosphate were elevated in patients with heart failure (150.0 versus 7.6 pmol/mL, P<0.01), and plasma cyclic guanosine monophosphate levels positively correlated with the fractional amount of cleaved pro-ANP (r(s)=0.59, P<0.03) but not with levels of uncleaved pro-ANP, implying that the cellular response to ANP remained intact.
CONCLUSIONS: Taken together, these data suggest that there may be patients for whom low corin levels and impaired pro-ANP cleavage contribute to acute decompensation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21216831      PMCID: PMC3840730          DOI: 10.1161/CIRCHEARTFAILURE.109.895581

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  60 in total

1.  Up-regulation of 'clearance' receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones.

Authors:  M G Andreassi; S Del Ry; C Palmieri; A Clerico; A Biagini; D Giannessi
Journal:  Eur J Heart Fail       Date:  2001-08       Impact factor: 15.534

2.  Processing of pro-atrial natriuretic peptide by corin in cardiac myocytes.

Authors:  Faye Wu; Wei Yan; Junliang Pan; John Morser; Qingyu Wu
Journal:  J Biol Chem       Date:  2002-03-07       Impact factor: 5.157

3.  Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme.

Authors:  W Yan; F Wu; J Morser; Q Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

4.  Localization of the mosaic transmembrane serine protease corin to heart myocytes.

Authors:  J D Hooper; A L Scarman; B E Clarke; J F Normyle; T M Antalis
Journal:  Eur J Biochem       Date:  2000-12

5.  Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin.

Authors:  Sabine Knappe; Faye Wu; Mary Rose Masikat; John Morser; Qingyu Wu
Journal:  J Biol Chem       Date:  2003-10-14       Impact factor: 5.157

6.  Plasma brain natriuretic peptide concentration: impact of age and gender.

Authors:  Margaret M Redfield; Richard J Rodeheffer; Steven J Jacobsen; Douglas W Mahoney; Kent R Bailey; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2002-09-04       Impact factor: 24.094

Review 7.  Mechanisms of renal hyporesponsiveness to ANP in heart failure.

Authors:  A Charloux; F Piquard; S Doutreleau; G Brandenberger; B Geny
Journal:  Eur J Clin Invest       Date:  2003-09       Impact factor: 4.686

8.  Rat corin gene: molecular cloning and reduced expression in experimental heart failure.

Authors:  Thomas H Langenickel; Ines Pagel; Jens Buttgereit; Katja Tenner; Maren Lindner; Rainer Dietz; Roland Willenbrock; Michael Bader
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05-20       Impact factor: 4.733

Review 9.  Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea.

Authors:  Sean P Collins; Sarah Ronan-Bentle; Alan B Storrow
Journal:  Ann Emerg Med       Date:  2003-04       Impact factor: 5.721

10.  Cyclic GMP production by ANP, BNP, and NO during worsening and improvement of chronic heart failure.

Authors:  Motoi Takahashi; Sadao Takeda; Shingo Kurokawa; Takaaki Kubo; Naoto Fukuda; Tohru Izumi
Journal:  Jpn Heart J       Date:  2003-09
View more
  54 in total

1.  Human corin isoforms with different cytoplasmic tails that alter cell surface targeting.

Authors:  Xiaofei Qi; Jingjing Jiang; Mingqing Zhu; Qingyu Wu
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

2.  Plasma corin decreases after coronary artery bypass graft surgery and is associated with postoperative heart failure: a pilot study.

Authors:  Caryn S Barnet; Xiaoxia Liu; Simon C Body; Charles D Collard; Stanton K Shernan; Jochen D Muehlschlegel; Petr Jarolim; Amanda A Fox
Journal:  J Cardiothorac Vasc Anesth       Date:  2014-11-11       Impact factor: 2.628

Review 3.  Corin in natriuretic peptide processing and hypertension.

Authors:  Yiqing Zhou; Qingyu Wu
Journal:  Curr Hypertens Rep       Date:  2014-02       Impact factor: 5.369

Review 4.  Rationale and therapeutic opportunities for natriuretic peptide system augmentation in heart failure.

Authors:  Paul M McKie; John C Burnett
Journal:  Curr Heart Fail Rep       Date:  2015-02

5.  Pro-B-type natriuretic peptide-1-108 processing and degradation in human heart failure.

Authors:  Brenda K Huntley; Sharon M Sandberg; Denise M Heublein; S Jeson Sangaralingham; John C Burnett; Tomoko Ichiki
Journal:  Circ Heart Fail       Date:  2014-10-22       Impact factor: 8.790

6.  Sex-specific association between soluble corin and metabolic syndrome in Chinese adults.

Authors:  Hongmei Li; Qiu Zhang; Yan He; Jijun Shi; Weidong Hu; Hao Peng
Journal:  Hypertens Res       Date:  2019-02-14       Impact factor: 3.872

Review 7.  BNP molecular forms and processing by the cardiac serine protease corin.

Authors:  Tomoko Ichiki; Brenda K Huntley; John C Burnett
Journal:  Adv Clin Chem       Date:  2013       Impact factor: 5.394

8.  Current Understanding of the Compensatory Actions of Cardiac Natriuretic Peptides in Cardiac Failure: A Clinical Perspective.

Authors:  Noel S Lee; Lori B Daniels
Journal:  Card Fail Rev       Date:  2016-05

9.  Identification and functional analysis of CORIN variants in hypertensive patients.

Authors:  Yue Zhang; Tiantian Zhou; Yayan Niu; Meiling He; Can Wang; Meng Liu; Junhua Yang; Yonghong Zhang; Jianping Zhou; Koichi Fukuda; Jun Qin; Ningzheng Dong; Qingyu Wu
Journal:  Hum Mutat       Date:  2017-09-26       Impact factor: 4.878

10.  Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis.

Authors:  Tomoko Ichiki; Guido Boerrigter; Brenda K Huntley; S Jeson Sangaralingham; Paul M McKie; Gail J Harty; Gerald E Harders; John C Burnett
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-11-14       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.